Clin2
NCT07787156Possibly a fitNot yet recruiting

Genetic testing for pancreatic cancer risk

Pancreatic Ductal Adenocarcinoma (PDAC)Family History of Pancreas CancerGenetic TestingMulti-cancer Early Detection

Part of Cancer, Digestive system, Hormones & metabolism clinical trials.

This study offers genetic testing and counseling for people at higher risk of pancreatic cancer. It aims to see if offering these services helps people learn about their risk and get screened earlier.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
80 people
Ages
18 years and older
Study type
Interventional

Who can take part

  • You are 50 or older, or within 10 years of the age your family member was when they were diagnosed with pancreatic cancer.
  • You have Medicaid, and/or you are Black or Latino/a.
  • You live in Massachusetts and can travel to Boston if needed.
  • You have a parent, brother, sister, or child with pancreatic cancer, or a blood relative with a known gene change linked to pancreatic cancer.
  • You have not had genetic testing for pancreatic cancer risk before.
  • You can complete surveys in English online.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07358208Enrolling by invitation
Pancreas cancer family registry study

This study is building a registry of people with a strong family history of pancreatic cancer. By joining, you help researchers learn more about who is at risk and how to detect it early.

Rochester, Minnesota
NCT02775461Recruiting
Registry for people at high risk for pancreatic cancer

This study is a registry (a way to track health over time) for people with a strong family history or certain inherited genetic risks for pancreatic cancer. It may help doctors learn how best to monitor and protect high-risk people, and to see who benefits most from follow-up.

New York, New York
NCT06122896Recruiting· Early Phase 1
Screening for pancreatic cancer in high-risk people

This trial uses MRI and endoscopic ultrasound to look for early signs of pancreatic cancer in people who have a high risk due to their genes or family history. Finding it early may lead to better treatment options.

Boston, Massachusetts
NCT03250078Recruiting
Pancreatic cancer screening for people at high genetic risk

This study offers pancreatic cancer screening for people with strong family history or certain inherited gene changes. It may help find pancreatic cancer earlier, when treatment may be more effective.

Norwalk, Connecticut
NCT05470920Recruiting
Genetic testing help tool for ovarian or pancreatic cancer

This study tests a decision aid that helps people with ovarian or pancreatic cancer understand and decide about genetic (inherited) testing. It may help you make a clearer choice about next steps for yourself and your family.

Boston, Massachusetts
NCT06744595Enrolling by invitation
Genetic counseling for people with a family history of pancreatic cancer

This study offers personalized education and genetic counseling to help people with a close family history of pancreatic cancer understand their risk and decide about genetic testing. It is only for current Mayo Clinic Florida patients in certain clinics.

Jacksonville, Florida

Hear when a new Pancreatic Ductal Adenocarcinoma (PDAC) trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.